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Abstract
The present study was undertaken to elucidate the functional characteristics of choline uptake and deduce the relationship
between choline uptake and the expression of organic cation transporters in the rat brain microvessel endothelial cell line
RBE4. Confluent RBE4 cells were found to express a high affinity choline uptake system. The system is Na-independent
and shows a Michaelis^Menten constant of approx. 20 WM for choline. The choline analogue hemicholinium-3 inhibits
choline uptake in these cells with an inhibition constant of approx. 50 WM. The uptake system is also susceptible for
inhibition by various organic cations, including 1-methyl-4-phenylpyridinium, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
clonidine, procainamide, and tetramethylammonium. The prototypical organic cation tetraethylammonium shows very little
affinity for the choline uptake system in these cells. The inhibition of choline uptake by hemicholinium-3 is competitive.
Northern analysis and RT-PCR show that these cells do not express the organic cation transporters OCT2 and OCT3. These
cells do express, however, low levels of OCT1, but the functional characteristics of choline uptake in these cells are very
different from the known properties of choline uptake via OCT1. The Na-coupled high affinity choline transporter CHT1 is
not expressed in these cells as evidenced by RT-PCR. This corroborates the Na-independent nature of choline uptake in
these cells. It is concluded that RBE4 cells express an organic cation transporter that is responsible for choline uptake in these
cells and that this transporter is not identical to any of the organic cation transporters thus far identified at the molecular
level in mammalian cells. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Choline is an organic cation that plays a critical
role in the structure and function of biological mem-
branes in all cells as a component of the membrane
phospholipid phosphatidylcholine. In the brain, cho-
line plays an additional role as a precursor for the
synthesis of the neurotransmitter acetylcholine [1^3].
Since the synthesis of phosphatidylcholine as well as
acetylcholine occurs intracellularly, availability of
choline for these synthetic processes inside the cell
is controlled primarily by the transport systems lo-
cated in the plasma membrane of the cell. In addi-
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tion, the entry of choline from the systemic circula-
tion into the brain occurs via transport systems
present in the blood^brain barrier. This transport
process is important because brain has only a limited
capacity to synthesize choline and consequently de-
pends predominantly on the transfer of choline from
the systemic circulation [4]. The endothelial cells of
the microvasculature in the brain constitute a selec-
tive permeability barrier that is characteristic of the
blood^brain barrier. These cells exhibit a unique phe-
notype with the presence of a complex network of
tight junctions and the absence of fenestrations and
vesicular transcytosis [5]. Transcellular transfer of
solutes across the endothelial cell layer of the
blood^brain barrier requires di¡erential expression
of distinct transport systems in the lumenal mem-
brane facing the vascular lumen and the basolateral
membrane facing the extracellular £uid of the brain
tissue [6]. The transport of choline across the blood^
brain barrier has been investigated in intact animals
[7,8], with isolated brain capillaries [9^11] or puri¢ed
brain capillary endothelial cells [11,12]. A more re-
cent study has used a mouse brain capillary endothe-
lial cell line to investigate choline transport [13].
These studies have demonstrated the presence of a
carrier-mediated process for the entry of choline
across the endothelial cell layer of the blood^brain
barrier. The process is mediated by a Na-independ-
ent high a⁄nity transporter that exhibits a Michae-
lis^Menten constant of 10^20 WM for choline. Even
though these studies have established the functional
characteristics of the choline transport process in the
blood^brain barrier endothelial cells, nothing is
known at present on the molecular nature of the
transport protein that is responsible for the transport
process.
Three di¡erent transporters with ability to trans-
port organic cations have been cloned and function-
ally characterized [14]. These transporters, known as
organic cation transporter (OCT)1, OCT2, and
OCT3, exhibit a broad and overlapping substrate
speci¢city towards organic cations [15^21]. Choline
interacts with all three transporters with varying af-
¢nity. In addition, a Na-dependent high a⁄nity
choline transporter, designated CHT1, has been re-
cently cloned [22]. CHT1 is expressed exclusively in
speci¢c regions of the brain (forebrain, striatum,
brain stem, and spinal cord), strongly suggesting a
role for this transporter in cholinergic neurons [22].
The molecular identi¢cation of another choline
transporter, called CHOT1, has been reported by
Mayser et al. [23], but studies from other laboratories
have shown that CHOT1 does not transport choline
[24], that its expression pattern in the brain does not
match the location of cholinergic neurons [25], and
that CHOT1 is actually a Na- and Cl3-coupled
creatine transporter [24,25]. The present study was
undertaken to investigate the possible relationship
between choline transport and expression of the or-
ganic cation transporters OCT1^3 and the Na-de-
pendent choline transporter CHT1 in the endothelial
cells of the blood^brain barrier. For this purpose, we
used an immortalized rat brain microvessel endothe-
lial cell line (RBE4). This cell line has been shown to
display a nontransformed endothelial phenotype and
retains the sensitivity to angiogenic and astroglial
factors for the expression of blood^brain barrier-re-
lated enzymes [26]. The results of the present study
show the following: (a) RBE4 cells express a Na-
independent high a⁄nity transport process for cho-
line, (b) the transport process also interacts with var-
ious other organic cations, (c) these cells do not ex-
press the organic cation transporters OCT2 and
OCT3, but express at low levels the organic cation
transporter OCT1, (d) choline transport in these cells
is not mediated by OCT1, and (e) the Na-dependent
choline transporter CHT1 is not expressed in these
cells.
2. Materials and methods
2.1. Materials
[3H]Choline and [14C]tetraethylammonium (TEA)
were purchased from American Radiolabeled Chem-
icals (St. Louis, MO, USA). Unlabeled organic cat-
ions were obtained from either Sigma (St. Louis,
MO, USA) or Research Biochemicals (Natick, MA,
USA). Cell culture medium, fetal bovine serum, and
antibiotics were from Life Technologies (Gaithers-
burg, MD, USA). Rat tail collagen and basic ¢bro-
blast growth factor were obtained from Boehringer-
Mannheim (Indianapolis, IN, USA).
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2.2. Cell culture
The RBE4 cell line was kindly provided by Dr.
Franc°oise S. Roux (INSERM, Paris, France). The
cells were grown to con£uence at 37‡C in a humid
atmosphere of 5% CO2 on collagen (5 Wg/well)-
coated 24-well culture plates in K-minimum essential
medium/Ham’s F-10 (1:1), supplemented with 2 mM
glutamine, 10% fetal bovine serum, 1 Wg/l basic ¢bro-
blast growth factor, 300 mg/l geneticin, and 10 mg/l
gentamicin. Initial seeding was done at 2U104 cells/
well and the cultures became con£uent 2 days after
the seeding. Con£uent cultures were used for uptake
measurements.
2.3. Uptake measurements
Uptake measurements were made with con£uent
cells at room temperature. In most experiments, the
concentration of [3H]choline was 10 nM and the in-
cubation time was 10 min. Uptake of [14C]TEA was
measured at the concentration of 40 WM. Culture
medium was removed from the wells by aspiration
and the cells were washed once with the uptake bu¡-
er. Uptake was then started by the addition of 250 Wl
of uptake bu¡er containing radiolabeled choline or
TEA. After 10 min incubation, uptake was termi-
nated by the removal of the medium from the wells,
followed by the addition of 1 ml ice-cold phosphate-
bu¡ered saline. Cells were washed twice with ice-cold
phosphate-bu¡ered saline and then solubilized in
0.5 ml of 1% sodium dodecyl sulfate in 0.2 M
NaOH. The cell lysate was transferred to vials for
determination of radioactivity associated with the
cells. The composition of the uptake bu¡er was
25 mM HEPES/Tris (pH 7.5), supplemented with
140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2,
0.8 mM MgSO4, and 5 mM glucose. When the in£u-
ence of Na on the uptake process was studied, the
uptake bu¡er was modi¢ed by replacing NaCl with
equimolar concentration of N-methyl-D-glucamine
(NMDG) chloride. One well was reserved in each
culture plate for protein determination. In experi-
ments dealing with saturation kinetics, the concen-
tration of [3H]choline was kept constant at 20 nM
and unlabeled choline was added to give desired cho-
line concentrations. The nonsaturable component of
uptake was determined from the radioactivity asso-
ciated with the cells when the incubation was done
with 20 nM [3H]choline in the presence of 5 mM
unlabeled choline. Total uptake at each concentra-
tion of choline was adjusted for this nonsaturable
uptake to calculate the saturable component. Data
were analyzed by nonlinear regression and con¢rmed
by linear regression. Experiments were repeated two
or three times with independent cultures, each experi-
ment done in duplicate or triplicate. Results are ex-
pressed as means þ S.E. of these replicates.
2.4. Northern blot analysis
The expression of mRNAs for OCT1, OCT2, and
OCT3 in RBE4 cells was analyzed by Northern blot.
Poly(A) RNA was isolated from RBE4 cells using a
commercially available mRNA isolation kit (Invitro-
gen, San Diego, CA, USA). Poly(A) RNA from rat
kidney was used as a positive control for OCT1 and
OCT2 expression and poly(A) RNA from rat pla-
centa was used as a positive control for OCT3 ex-
pression. mRNA was size-fractionated on a denatur-
ing formaldehyde-agarose gel and probed with 32P-
labeled cDNAs speci¢c for the three organic cation
transporters (OCT1^3). OCT1 and OCT2 cDNAs
were isolated from a rat liver cDNA library and their
identities con¢rmed by sequencing. The nucleotide
sequences of these cDNAs were identical to the se-
quences reported in the literature [15,16]. OCT3
cDNA was isolated from a rat placental cDNA li-
brary [18]. The blots were also probed with 32P-la-
beled L-actin cDNA as an internal control for the
presence of RNA in each lane. The probes were la-
beled with [K-32P]dCTP by random priming using the
ready-to-go oligolabeling kit from Amersham-Phar-
macia Biotech (Piscataway, NJ, USA). Hybridization
and washing were carried out under high stringency
conditions.
2.5. Reverse transcription-polymerase chain reaction
(RT-PCR)
RT-PCR using poly(A) RNA isolated from
RBE4 cells was done with primer pairs speci¢c for
rat OCT1, OCT2, OCT3, and CHT1. Poly(A) RNA
from rat kidney was used as the positive control for
all three OCTs. Poly(A) RNA from rat brain stem
was used as the positive control for CHT1. The sense
BBAMEM 78102 28-5-01
A. Friedrich et al. / Biochimica et Biophysica Acta 1512 (2001) 299^307 301
and antisense primers for OCT1 were 5P-TGCAGA-
CAGGTTTGGCCGTAA-3P and 5P-TCGAGGC-
CGCTATTGGGTAGA-3P and the size of the
expected product was 722 bp. The sense and anti-
sense primers for OCT2 were 5P-GCTGGTT-
AATTGGCTACATCC-3P and 5P-TTCTTGGCC-
TCTGCATATTC-3P and the size of the expected
product was 960 bp. The sense and antisense primers
for OCT3 were 5P-CCACCATCGTCAGCCAGTTT-
3P and 5P-ACACGACACCCCTGCCACTA-3P and
the size of the expected product was 851 bp. The
sense and antisense primers for CHT1 were 5P-
GAACGCAGCGAAGCCATCATAGTTG-3P and
5P-CCACAGAGTAGAGCCCTCCCACGAG-3P and
the size of the expected product was 445 bp.
3. Results
3.1. Functional characteristics of choline uptake in
RBE4 cells
Fig. 1 describes the time course of the uptake of
choline in RBE4 cells in the presence and absence of
Na. The uptake was not stimulated by the presence
of a transmembrane Na gradient. In fact, the up-
take was slightly higher in the absence of Na. The
uptake was linear at least up to 10 min. We then
assessed the in£uence of extracellular pH on the up-
take process, both in the presence and in the absence
of Na (Fig. 2A). The uptake was found to be in-
hibited signi¢cantly (approx. 30%) when the extracel-
lular pH was changed from 7.5 to 5.5. This inhibition
caused by acid pH was seen in the presence as well as
absence of Na. The uptake was, however, not in£u-
Fig. 1. Time course of choline uptake in RBE4 cells. Uptake of
[3H]choline (10 nM) was measured in con£uent RBE4 cells for
various time periods (1^30 min) in the presence of either NaCl
(b) or NMDG chloride (a). The pH of the uptake bu¡er was
7.5. Results are means þ S.E. for four independent determina-
tions.
Fig. 2. (A) In£uence of pH on choline uptake. Uptake of
[3H]choline (10 nM) was measured in con£uent RBE4 cells with
a 10 min incubation in the presence of either NaCl (open bars)
or NMDG chloride (closed bars) at varying pH. Uptake bu¡ers
of varying pH were prepared by mixing appropriately the fol-
lowing two bu¡ers: 25 mM MES/Tris (pH 5.5) and 25 Tris/
HEPES (pH 8.5). Both bu¡ers contained 5.4 mM KCl, 1.8 mM
CaCl2, 0.8 mM MgSO4, 5 mM glucose, and either 140 mM
NaCl or 140 mM NMDG chloride. Results are means þ S.E.
for six independent determinations. (B) Inhibition of
[3H]choline uptake by various organic cations. Uptake of
[3H]choline (10 nM) was measured in con£uent RBE4 cells with
a 10 min incubation in the presence of NaCl at pH 7.5 either
in the absence (control) or presence of 2 mM organic cations.
Unlabeled choline was also used as a competitor of [3H]choline
uptake. Results (means þ S.E. for six independent determina-
tions) are given as percent of control uptake measured in the
absence of inhibitors (0.58 þ 0.01 pmol/mg of protein/10 min).
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enced when the pH was changed from 7.5 to 8.5.
Based on these data, subsequent uptake measure-
ments were made with a 10 min incubation in the
presence of Na at pH 7.5.
We investigated the substrate selectivity of the up-
take process that is responsible for choline uptake in
these cells. This was done by assessing the ability of
various organic cations (2 mM) to inhibit the uptake
of [3H]choline (10 nM). Several organic cations
were found to cause marked inhibition of choline
uptake (Fig. 2B). The inhibitors included tetrameth-
ylammonium (TMA), procainamide, clonidine, 1-
methyl-4-phenylpyridinium (MPP), 1-methyl-4-phe-
nyl-1,2,3,6-tetrahydropyridine (MPTP), and hemi-
cholinium-3. The order of inhibitory potency was
as follows: hemicholinium-3sMPTPsMPPs clo-
nidines procainamide = TMA. The inhibition ob-
served with these compounds was in the range of
70^95%. As expected, unlabeled choline competed
with [3H]choline for the uptake process, causing
100% inhibition. Interestingly, TEA caused only
about 15% inhibition. Cimetidine and serotonin
were also slightly inhibitory. Dopamine and norepi-
nephrine did not cause any signi¢cant inhibition. Fig.
3 shows the dose^response relationship for the inhi-
bition of [3H]choline uptake caused by TEA, MPP,
MPTP, hemicholinium-3, and unlabeled choline. Un-
labeled choline inhibited the uptake of [3H]choline
with an IC50 value (i.e., concentration at which the
inhibition was 50%) of 12 þ 1 WM. The choline ana-
logue hemicholinium-3 inhibited the uptake with an
IC50 value of 53 þ 5 WM. The IC50 values for MPP
and MPTP were 169 þ 10 WM and 273 þ 34 WM. TEA
Fig. 4. Saturation kinetics of choline uptake. Uptake of choline
was measured in con£uent RBE4 cells with a 10 min incubation
in the presence of NaCl at pH 7.5. The concentration of
[3H]choline was kept constant at 20 nM and unlabeled choline
was added to give the indicated choline concentrations. Nonsa-
turable uptake was calculated from the uptake of radioactivity
in the presence of an excess amount (5 mM) of unlabeled cho-
line. (Upper panel) Choline uptake versus choline concentra-
tion. The saturable component of uptake (b) was calculated by
subtracting the nonsaturable component (broken line) from the
total uptake (a) at each concentration of choline. (Lower pan-
el) Eadie^Hofstee plot of the saturable component of uptake.
V, uptake rate; V/S, uptake rate/choline concentration. Results
represent means þ S.E. for three independent determinations.
Fig. 3. Dose^response relationship for the inhibition of
[3H]choline uptake by various organic cations. Uptake of
[3H]choline (10 nM) was measured in con£uent RBE4 cells with
a 10 min incubation in the presence of NaCl at pH 7.5 either
in the absence (control) or presence of increasing concentrations
of various organic cations. Results (means þ S.E. for six inde-
pendent determinations) are given as percent of control uptake
measured in the absence of inhibitors (0.71 þ 0.06 pmol/mg of
protein/10 min). b, unlabeled choline; O, hemicholinium-3; F,
MPP; a, MPTP; E, TEA.
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was the least potent inhibitor among these com-
pounds with an IC50 value of 8.8 þ 0.9 mM.
We then analyzed the saturation kinetics of choline
uptake over the concentration range of 2.5^200 WM.
Fig. 4 (top) describes the total uptake and the non-
saturable component at each concentration of cho-
line. The saturable component represented s 80% of
total uptake at choline concentrations 2.5^50 WM.
Even at the highest concentration of choline em-
ployed in this experiment (200 WM), the nonsaturable
component represented only about 50% of total up-
take. The di¡erence between the total uptake and the
nonsaturable component showed saturation with in-
creasing concentrations of choline. Fig. 4 (bottom)
shows the linear transformation of the data for the
saturable component. The Michaelis^Menten con-
stant (Kt) for the saturable uptake was 23 þ 1 WM
and the maximal velocity (Vmax) was 516 þ 11 pmol/
mg of protein/10 min.
The inhibition of choline uptake by hemicholi-
nium-3 was competitive. Fig. 5 shows the Dixon
plot of the inhibition. In this experiment, the uptake
of choline was measured at two di¡erent concentra-
tions of choline (1 and 5 WM). The concentration of
hemicholinium-3 was varied over the range of 25^
250 WM. The Dixon plots (i.e., 1/uptake rate versus
hemicholinium-3 concentration) were linear at both
concentrations of choline and the lines intersected
above the X-axis, indicating the competitive nature
of the inhibition. The Ki value (i.e., inhibition con-
stant) was 65 WM.
3.2. Analysis of the expression of organic cation
transporters in RBE4 cells
We investigated the expression in RBE4 cells of
the three organic cation transporters (OCT1^3) iden-
ti¢ed thus far in mammalian cells. This was done ¢rst
by Northern analysis and then by RT-PCR. Fig. 6
describes the data from Northern analysis. These
studies showed no evidence of expression of any of
the three OCTs in RBE4 cells. The rat kidney was
positive for OCT1 and OCT2 and the rat placenta
was positive for OCT3 under identical conditions.
These two tissues were selected as positive controls
based on the known abundance of mRNA for each
of the three OCTs [15,16,18]. OCT1 and OCT2 are
expressed abundantly in rat kidney and OCT3 is ex-
pressed abundantly in rat placenta. However, L-actin
mRNA was detectable in the lane containing the
poly(A) RNA from RBE4 cells. Fig. 7 shows the
RT-PCR data. The experimental conditions used for
Fig. 5. Kinetic analysis of choline uptake by hemicholinium-3.
Uptake of choline at two di¡erent concentrations (1 and 5 WM)
was measured in con£uent RBE4 cells with a 10 min incubation
in the presence of NaCl at pH 7.5. The concentration of
[3H]choline was kept constant at 20 nM in both cases. Uptake
was measured either in the absence or presence of increasing
concentrations of hemicholinium-3. Results are given as Dixon
plots (1/choline uptake in nmol/mg of protein/10 min versus
hemicholinium-3 concentration in WM) with 1 WM (b) and
5 WM (R) choline. Results represent means þ S.E. for six inde-
pendent determinations.
Fig. 6. Northern blot analysis of the expression of organic cat-
ion transporters in RBE4 cells. Poly(A) RNA, isolated from
RBE4 cells, rat kidney and rat placenta, was size-fractionated
on a denaturing formaldehyde-agarose gel and probed by se-
quential hybridization under high stringency conditions with
32P-labeled cDNAs speci¢c for rat OCT1, OCT2, OCT3, and
L-actin. Rat kidney (RK) was used as a positive control for
OCT1 and OCT2 and rat placenta (RP) was used as a positive
control for OCT3.
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RT-PCR were validated by demonstrating the RT-
PCR products of expected sizes for OCT1, OCT2,
and OCT3 with rat kidney mRNA. As expected,
OCT1 and OCT2 were expressed abundantly in rat
kidney. The expression of OCT3 in rat kidney was
lower than that of OCT1 and OCT2, again corrob-
orating the earlier ¢ndings [15,16,18]. Under similar
conditions, RT-PCR was negative for OCT2 and
OCT3 with RBE4 cell mRNA, showing lack of ex-
pression of these two organic cation transporters in
these cells. However, the expression of OCT1 was
detectable in these cells. Thus, even though Northern
analysis indicated that OCT1 was not expressed in
RBE4 cells, the more sensitive RT-PCR was able to
detect the presence of OCT1 mRNA in these cells.
The level of expression of OCT1 in RBE4 cells was,
however, much lower than that in rat kidney. Taken
collectively, these data demonstrate that RBE4 cells
do not express OCT2 and OCT3, but express low
levels of OCT1. The RT-PCR data also show that
RBE4 cells do not express the Na-dependent cho-
line transporter CHT1 (Fig. 7). Poly(A) RNA from
rat brain stem, used as the positive control for CHT1
expression, yielded the expected RT-PCR product
for CHT1. The lack of expression of CHT1 in
RBE4 cells agrees with the present ¢ndings that there
is no detectable Na-dependent choline uptake in
these cells.
Since OCT1 mRNA was detectable in RBE4 cells,
it became necessary to assess if OCT1-speci¢c trans-
port function was detectable in these cells. OCT1 has
been shown to transport choline and TEA [17]. The
Michaelis^Menten constants for the transport of
choline and TEA through OCT1 are approx.
600 WM and approx. 100 WM, respectively. There-
fore, we ¢rst measured the uptake of choline at
500 WM, an appropriate concentration for interaction
of choline with OCT1, and assessed if the uptake of
choline at this concentration was inhibitable by 2 mM
TEA. These experiments showed that choline uptake
under these conditions was not inhibited by TEA
(choline uptake in the absence of TEA, 2.53 þ 0.18
nmol/mg of protein/10 min; choline uptake in the
presence of TEA, 2.51 þ 0.16 nmol/mg of protein/10
min). Similarly, we measured the uptake of TEA at
40 WM and assessed if the uptake of TEA at this
concentration was inhibitable by 5 mM choline.
These studies showed that TEA uptake under these
conditions was not inhibited by choline (TEA uptake
in the absence of choline, 33.33 þ 3.7 pmol/mg of
protein/10 min; TEA uptake in the presence of cho-
line, 31.0 þ 6.5 pmol/mg of protein/10 min). We con-
clude from these data that even though OCT1
mRNA is detectable at low levels in RBE4 cells,
there is no detectable transport function in these cells
that can be ascribed speci¢cally to OCT1.
4. Discussion
The functional characteristics of choline uptake in
Fig. 7. RT-PCR. Poly(A) RNA samples from RBE4 cells and
rat kidney (RK) were used for RT-PCR with primer pairs spe-
ci¢c for rat OCT1, rat OCT2, and rat OCT3. The RT-PCR
products were size-fractionated with molecular size markers run
in parallel. For RT-PCR with primer pairs speci¢c for rat
CHT1, poly(A) RNA from rat brain stem served as the posi-
tive control.
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RBE4 cells deduced from the present study can be
summarized as follows: (a) RBE4 cells express a sat-
urable transport system for the uptake of choline,
(b) the transport system is Na-independent and ex-
hibits high a⁄nity for choline with a Kt value of 10^
20 WM, (c) the choline analogue hemicholinium-3
competes with choline with a Ki value of 50^65
WM, (d) the transport system recognizes several other
organic cations including MPP, MPTP, clonidine,
procainamide, and TMA as substrates, (e) mono-
amines (e.g., dopamine, serotonin, and norepinephr-
ine) exhibit little or no a⁄nity for the transport sys-
tem, and (f) TEA, a prototypical organic cation that
is used widely in studies involving the transport of
organic cations, interacts with the transport system
with very low a⁄nity (IC50 value, approx. 10 mM).
Based on the kinetic data, we speculate that a single
transport system is responsible for choline uptake in
these cells. It is, however, possible, though unlikely,
that the observed choline uptake is mediated by more
than one transport system that are kinetically indis-
tinguishable. The kinetic characteristics of the cho-
line transport system in RBE4 cells are very similar
to those reported recently by Sawada et al. [13] in the
mouse brain capillary endothelial cell line MBEC4.
Choline uptake in MBEC4 cells was also found to be
Na-independent and saturable with a Kt value for
choline of approx. 20 WM. However, there are nota-
ble di¡erences between RBE4 cells and MBEC4 cells
in the potencies with which various organic cations
compete with choline for the uptake process. Hemi-
cholinium-3 inhibits choline uptake in MBEC4 cells
with an IC50 value of approx. 700 WM which is an
order of magnitude higher than the IC50 value found
in RBE4 cells (approx. 50 WM). Similarly, procaina-
mide at a concentration of 2 mM inhibited choline
uptake in RBE4 cells by more than 50%, indicating
that the IC50 value for the inhibition is much lower
than 2 mM. In contrast, the IC50 value for the inhi-
bition of choline uptake by procainamide in MBEC4
cells is considerably much higher (approx. 7 mM)
than in RBE4 cells. The inhibition data with mono-
amines are, however, comparable in both cell types.
It is surprising that while the kinetic parameters of
choline uptake are similar between RBE4 cells and
MBEC4 cells, the inhibitory potencies for various
organic cations are signi¢cantly di¡erent between
these two cell types. The reasons for these discrep-
ancies are not known.
The primary purpose of the present study was to
investigate the relationship between choline uptake
and the expression of organic cation transporters in
RBE4 cells. This is the ¢rst study in the literature to
address this issue. Among the three di¡erent organic
cation transporters thus far identi¢ed in mammalian
cells at the molecular level, OCT1 and OCT2 trans-
port choline [17]. The transport process is Na-inde-
pendent and has a Kt value of approx. 0.6 mM in the
case of OCT1 and approx. 0.2 mM in the case of
OCT2. OCT3 does not recognize choline as a sub-
strate [18,20,21]. RBE4 cells do not express OCT2
and OCT3, but contain detectable levels of OCT1
mRNA, indicating a low but signi¢cant expression
of this transporter. Even though OCT1 mRNA is
expressed at low, but detectable, levels in RBE4 cells,
there is no detectable transport function in these cells
that can be ascribed speci¢cally to OCT1. Choline
transport reported in the present study does not ap-
pear to be mediated by OCT1. The a⁄nity of rat
OCT1 for choline is about 30 times lower than found
in RBE4 cells (Kt for rat OCT1, 600 WM; Kt in
RBE4 cells, 20 WM). Furthermore, rat OCT1 trans-
ports TEA with a Kt value of approx. 100 WM where-
as the choline transport system identi¢ed in RBE4
cells interacts with TEA with very low a⁄nity. The
IC50 value for TEA to inhibit choline uptake in these
cells is about 80 times higher than the Kt value for
TEA for transport via rat OCT1. Similarly, MPP is
transported by rat OCT1 with very high a⁄nity (Kt,
approx. 10 WM), but the IC50 value for MPP to in-
hibit choline uptake in RBE4 cells is approx. 170 WM.
These data clearly show that even though RBE4 cells
express low levels of OCT1, the high a⁄nity Na-
independent choline uptake detected in these cells
does not occur via OCT1. This suggests that a hith-
erto unidenti¢ed organic cation transporter is re-
sponsible for choline uptake in RBE4 cells.
There are at least two distinct high a⁄nity trans-
port systems for choline in the brain, both being
sensitive to inhibition by hemicholinium-3 [27,28].
These two systems are distinguished primarily by
their dependence on Na. One of the systems is ener-
gized by a transmembrane Na gradient and exhibits
very high a⁄nity for choline (Kt, approx. 1 WM) and
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hemicholinium-3 (Ki, 6 10 WM). The other is Na-
independent and exhibits a Kt value of approx. 20
WM for choline and a Ki value of approx. 50 WM for
hemicholinium-3. The Na-dependent choline trans-
porter, designated CHT1, has been recently cloned
[22]. The functional characteristics of choline uptake
in RBE4 cells strongly suggest that the Na-depen-
dent choline transporter is not expressed in these
cells. This is supported by RT-PCR data that show
lack of expression of CHT1 mRNA in these cells.
The properties of the Na-independent choline trans-
porter described in the brain bears marked similarity
to those of the choline uptake process in RBE4 cells.
A similar transport system has been described not
only in the brain but also in various epithelial cells
derived from nonneuronal tissues [22,29^31]. There-
fore, it appears that the expression of the Na-inde-
pendent high a⁄nity choline transport system may
not be restricted to the central nervous system.
This system is likely to play a critical role in the
delivery of choline in various cell types of neuronal
as well as nonneuronal origin. The expression of this
transport system in RBE4 cells indicates that this
transporter also participates in the delivery of choline
to the brain across the blood^brain barrier. How-
ever, the molecular identity of this transporter re-
mains unknown.
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